focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares, ADS

Tue, 25th Feb 2014 12:50

LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives including Roger Connor a divisional president and Philip Thomson, a divisional senior vice president acquired shares while General Counsel James Ford and Executive Director Moncef Slaoui acquired American Depositary Shares as a resulting of the vesting of awards under the company share value plan Monday.

Details are as follows.

Name of PDMR

Number of Ordinary Shares vested

Number of ADS  vested

Mr R Connor

8,230

 

Mr J Ford

 

5,740

Mr P Thomson

10,050

 

Mrs V Whyte

10,050

 

Name of

Director / PDMR

Name of Connected person

Number of Ordinary Shares vested

Number of ADS  vested

Mr P Thomson

Mrs K Thomson

2,210

 

Dr M Slaoui*

Mrs K Slaoui

 

2,450

 
Glaxo shares were trading down 1.2% at 1,663.00 pence Tuesday.



By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright © 2014 Alliance News Limited. All Rights Reserved.

Related Shares

More News
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030 *

21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatm...

21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating seve...

20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares ...

17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake *

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.